BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 37364535)

  • 1. Lower Body Mass Index and Prognostic Nutritional Index Are Associated with Poor Posttransplant Outcomes in Lymphoma Patients Undergoing Autologous Stem Cell Transplantation.
    Yucel OK; Vural E; Alhan N; Vurgun S; Atas U; Yapar D; Alemdar MS; Karaca M; Iltar U; Salim O; Undar L
    Oncology; 2023; 101(11):753-764. PubMed ID: 37364535
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Prognostic significance of (18)F-fluorodeoxyglucose positron emission tomography in patients with diffuse large B cell lymphoma undergoing autologous stem cell transplantation].
    Ying ZT; Mi L; Wang XJ; Zhang YW; Yang Z; Song YQ; Wang XP; Zheng W; Lin NJ; Tu MF; Xie Y; Ping LY; Zhang C; Liu WP; Deng LJ; Zhu J
    Zhonghua Xue Ye Xue Za Zhi; 2018 May; 39(5):382-386. PubMed ID: 29779346
    [No Abstract]   [Full Text] [Related]  

  • 3. Efficacy of chimeric antigen receptor T cell therapy and autologous stem cell transplant in relapsed or refractory diffuse large B-cell lymphoma: A systematic review.
    Tian L; Li C; Sun J; Zhai Y; Wang J; Liu S; Jiang Y; Wu W; Xing D; Lv Y; Guo J; Xu H; Sun H; Li Y; Li L; Zhao Z
    Front Immunol; 2022; 13():1041177. PubMed ID: 36733398
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pretransplantation Inflammatory and Nutritional Status in Elderly Allogeneic Hematopoietic Stem Cell Transplantation: Prognostic Value of C-Reactive Protein-to-Albumin Ratio.
    Miyazaki T; Tachibana T; Suzuki T; Izumi A; Fujimaki K; Sato S; Tamai Y; Michishita Y; Suzuki T; Ishii R; Hirasawa A; Hashimoto C; Kabasawa N; Inoue Y; Ishiyama T; Yamamoto K; Kanamori H; Tanaka M; Nakajima H
    Transplant Cell Ther; 2024 Apr; 30(4):400.e1-400.e9. PubMed ID: 38253183
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [A comparative study of induction chemotherapy with or without autologous hematopoietic stem cell transplantation in the treatment of newly diagnosed young medium/high risk diffuse large B cell lymphoma patients].
    Wang X; Xia B; Wang CY; Li MZ; Xu W; Yuan T; Tian C; Zhao HF; Yang HL; Zhao ZG; Wang XF; Wang YF; Yu Y; Zhang YZ
    Zhonghua Xue Ye Xue Za Zhi; 2019 Feb; 40(2):117-124. PubMed ID: 30831626
    [No Abstract]   [Full Text] [Related]  

  • 6. A multicenter retrospective study on the real-world outcomes of autologous vs. allogeneic hematopoietic stem cell transplantation for peripheral T-cell lymphoma in China.
    Gu ZY; Dong YJ; Fu XR; Li NN; Liu Y; Wu XX; Wang YN; Li YH; Ren HY; Zhang MZ; Li XF; Wang MH; Wu YM; Liu DH; Wang Z; Hu LD; Huang WR
    Chin Med J (Engl); 2021 Jun; 134(13):1584-1592. PubMed ID: 34133361
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A Nutrition-Related Factor-Based Risk Stratification for Exploring the Clinical Benefits in the Treatment of Patients With Locally Advanced Esophageal Squamous Cell Carcinoma Receiving Definitive Chemoradiotherapy: A Retrospective Cohort Study.
    Yu Y; Wu H; Qiu J; Ke D; Wu Y; Lin M; Liu T; Zheng Q; Zheng H; Yang J; Wang Z; Li H; Liu L; Yao Q; Li J; Cheng W; Chen X
    Front Nutr; 2022; 9():896847. PubMed ID: 35990358
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Selection of hematopoietic stem cell transplantation for T-cell lymphoblastic lymphoma.
    Li Z; Zhang B; Fan X; Gui R; Yu F; Wang J; Zhang Y; Zhou K; Liu Y; Li Y; Ding J; Song Y; Zhou J
    Front Oncol; 2023; 13():1193237. PubMed ID: 37546390
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Efficacy and prognostic factors of allogeneic hematopoietic stem cell transplantation treatment for T lymphoblastic leukemia/lymphoma].
    Luo L; Jiao Y; Yang P; Li Y; Huang WY; Ke XY; Zou DH; Jing HM
    Zhonghua Xue Ye Xue Za Zhi; 2023 May; 44(5):388-394. PubMed ID: 37550188
    [No Abstract]   [Full Text] [Related]  

  • 10. [Outcomes of 33 patients with anaplastic large cell lymphoma treated after hematopoietic stem cell transplantation].
    Lu N; Li XF; Dong YJ; Wang YN; Fu XR; Wu YM; Li YH; Wang MH; Li NN; Ren HY; Wang Z; Zhang MZ; Wu XX; Hu LD; Liu Y; Huang WR
    Zhonghua Xue Ye Xue Za Zhi; 2020 Feb; 41(2):117-122. PubMed ID: 32135627
    [No Abstract]   [Full Text] [Related]  

  • 11. Prognostic value of
    Ying Z; Mi L; Zhou N; Wang X; Yang Z; Song Y; Wang X; Zheng W; Lin N; Tu M; Xie Y; Ping L; Zhang C; Liu W; Deng L; Zhu J
    Chin J Cancer Res; 2019 Feb; 31(1):162-170. PubMed ID: 30996574
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Obesity is associated with an impaired survival in lymphoma patients undergoing autologous stem cell transplantation.
    Scheich S; Enßle JC; Mücke VT; Acker F; Aspacher L; Wolf S; Wilke AC; Weber S; Brunnberg U; Serve H; Steffen B
    PLoS One; 2019; 14(11):e0225035. PubMed ID: 31703102
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Predictive value of nutritional indicators with regard to the survival outcomes in patients with metastatic esophageal squamous cell carcinoma treated with camrelizumab.
    Liu J; Hu G; Zhai C; Wang J; Xu W; Xie J; Zhu W; Jiang P; Liu D
    Oncol Lett; 2023 May; 25(5):198. PubMed ID: 37113404
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Clinical Efficacy of Autologous Hematopoietic Stem Cell Transplantation for Patients with Diffuse Large B-Cell Lymphoma].
    Fan D; Liu Q; Xiao F; Guo HX; Zhao H; Yan XQ; Liu L
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2021 Aug; 29(4):1163-1168. PubMed ID: 34362497
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The International Prognostic Index assessed at relapse predicts outcomes of autologous transplantation for diffuse large-cell non-Hodgkin's lymphoma in second complete or partial remission.
    Lerner RE; Thomas W; Defor TE; Weisdorf DJ; Burns LJ
    Biol Blood Marrow Transplant; 2007 Apr; 13(4):486-92. PubMed ID: 17382255
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of Risk Factors and Long Term Survival Analysis of Patients With Primary Refractory Hodgkin Lymphoma Who Underwent High Dose Chemotherapy and Autologous Stem Cell Transplant.
    Akhtar S; Rauf MS; Elhassan TAM; Khan ZA; Elshenawy MA; Maghfoor I
    Transplant Cell Ther; 2023 Jul; 29(7):451.e1-451.e12. PubMed ID: 37031748
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tandem autologous hematopoietic stem cell transplantation for treatment of adult T-cell lymphoblastic lymphoma: a multiple center prospective study in China.
    Liu Y; Rao J; Li J; Wen Q; Wang S; Lou S; Yang T; Li B; Gao L; Zhang C; Kong P; Gao L; Wang M; Zhu L; Xiang X; Zhou S; Liu X; Peng X; Zhong J; Zhang X
    Haematologica; 2021 Jan; 106(1):163-172. PubMed ID: 31780634
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Autologous hematopoietic stem cell transplantation treatment for T cell lymphoblastic lymphoma].
    Wang P; Li CX; Zhang Y; Chen J; Chen XC; Yang D; Zhou J; Zong XP; Yang Z; Wu M; Yang MZ; Song YQ; Zhu J; Wu DP
    Zhonghua Xue Ye Xue Za Zhi; 2020 Mar; 41(3):198-203. PubMed ID: 32311888
    [No Abstract]   [Full Text] [Related]  

  • 19. Controlling Nutritional Status (CONUT) score is a prognostic marker in III-IV NSCLC patients receiving first-line chemotherapy.
    Zhang Y; Kong FF; Zhu ZQ; Shan HX
    BMC Cancer; 2023 Mar; 23(1):225. PubMed ID: 36894927
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [The prognostic significance of pretransplantation evaluation of IPSS-R and WPSS in patients with myelodysplastic syndrome undergoing allogeneic hematopoietic stem cell transplantation].
    Lu CQ; Hou C; Wang P; Zhang LW; Fan Y; Wu DP; Xu Y
    Zhonghua Xue Ye Xue Za Zhi; 2022 Mar; 43(3):247-254. PubMed ID: 35405784
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.